Appalachian Node

Principal Investigators:
Jane Liebschutz, MD, MPH [email]
University of Pittsburgh School of Medicine
200 Lothrop St., Suite 933W
Pittsburgh, PA 15213

Erin L. Winstanley, PhD [email]
University of Pittsburgh
230 McKee Place, 6th Floor
Pittsburgh, PA 15213

Related Resources

Node web site
NIDA web site

The Appalachian Node joined the CTN in 2019 and is a collaboration between University of Pittsburgh, West Virginia University, and Penn State University, with a team of accomplished clinical and research collaborators. It organizes and participates in national, community-based multi-site trials and subsequently disseminates research findings to physicians, clinicians, providers, and patients.

Grantee Institutions: University of Pittsburgh, West Virginia University, and Penn State University.

Protocol Involvement

• CTN-0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): A Pragmatic Randomized Trial Comparing Two Buprenorphine Formulations (NIH HEAL Initiative)
• CTN-0099: Emergency Department-INitiated bupreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION)
• CTN-0100: Optimizing Retention, Duration, and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy
• CTN-0101: Subthreshold Opioid Use Disorder Prevention (STOP) Trial
• CTN-0115: Developing an Intervention to Address Intersecting Prescription Opioid and Chronic Pain Stigma in Cancer Survivors
• CTN-0119: Impact of Social Distancing Measures, Expansion of Telemedicine for Buprenorphine Prescribing, and Health Insurance Payor on Access to Buprenorphine During the COVID-19 Pandemic
• CTN-0135: Buprenorphine Treatment Engagement and Induction Problems Among Individuals Using Fentanyl
• CTN-0139: Collaborative Care for Polysubstance use in Primary Care Settings (Co-Care)